09Apr 2022
Removal of Small Cavernous Hemangioma in Orbital Apex Through an Endoscopic Transethmoidal‐Sphenoidal Approach

Removal of Small Cavernous Hemangioma in Orbital Apex Through an Endoscopic Transethmoidal‐Sphenoidal Approach

To investigate the feasibility, efficacy, and safety of an endoscopic transethmoidal‐sphenoidal approach in removing a small cavernous hemangioma (CH) located in the deep lateral orbital apex. All tumors in this study were completely removed. The mean BCVA was LogMAR 0.97 ± 0.97 preoperatively and LogMAR 0.38 ± 0.64 postoperatively (p < 0.05). The mean visual field index was 52.26% ± 33.26% preoperatively and 75.47% ± 30.49% postoperatively (p < 0.05). The mean deviation index was −17.48 ± 12.43 dB preoperatively and −10.10 ± 10.85 dB postoperatively (p < 0.05), and the pattern standard deviation was 6.37 ± 3.77 dB preoperatively and 4.90 ± 3.56 dB postoperatively (p > 0.05). Four (21.1%) patients developed oculomotor limitations and two (10.5%) patients developed ptosis after surgery. All of these symptoms resolved spontaneously, and no other complications occurred. The mean follow‐up time was 6.71 ± 3.89 months. The endoscopic transethmoidal‐sphenoidal approach is an effective and minimally invasive treatment for removing small CH in the deep lateral orbital apex.

  • #ent

Like

Save

Share